Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laura Vernoux"'
Autor:
Laura Vernoux, Séverine Mercier-Delarue, Jeanne Perpétue Vincent, François Simon, Yusuke Shimakawa, Sarah Maylin, Audrey Gabassi
Publikováno v:
Journal of Viral Hepatitis
Journal of Viral Hepatitis, Wiley-Blackwell, 2021, 28 (5), pp.837-843. ⟨10.1111/jvh.13489⟩
Journal of Viral Hepatitis, 2021, 28 (5), pp.837-843. ⟨10.1111/jvh.13489⟩
Journal of Viral Hepatitis, Wiley-Blackwell, 2021, 28 (5), pp.837-843. ⟨10.1111/jvh.13489⟩
Journal of Viral Hepatitis, 2021, 28 (5), pp.837-843. ⟨10.1111/jvh.13489⟩
International audience; Limited access to nucleic acid testing (NAT) to quantify HBV DNA levels, an essential tool to determine anti-HBV treatment eligibility, represents a significant barrier to scale up HBV diagnostic services in resource-limited c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc072cc9087b796de4e7083fec601429
https://hal-pasteur.archives-ouvertes.fr/pasteur-03697743/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-03697743/document
Autor:
Manu Vandijck, Laura Vernoux, Nathalie Le Bastard, Sylvie Chevalier, Roger Moonen, Martine Dauwe, Annick Barthelaix, Geert Jannes, Els Huyck, Vesna Kostanjevecki, Els Coart
Publikováno v:
Alzheimer's & Dementia. 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e7a508fed5700e1672fa900da5bdc7d
https://doi.org/10.1016/j.jalz.2016.06.931
https://doi.org/10.1016/j.jalz.2016.06.931
Autor:
Vesna Kostanjevecki, Manu Vandijck, Laura Vernoux, Nathalie Le Bastard, Roger Moonen, Susanna Schraen, John Lawson, Els Huyck
Publikováno v:
Alzheimer's & Dementia. 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80f2b6184ba03bca0ad2af97c678d32d
https://doi.org/10.1016/j.jalz.2016.06.1504
https://doi.org/10.1016/j.jalz.2016.06.1504
Autor:
Régis Bordet, Jean-François Dartigues, Bruno Dubois, Jean-Marie Goehrs, Laura Vernoux, Franck Semah, Florence Pasquier, Claude Bidaut-Mazel, Zeina Antoun, Olivier Arnaud, Olivier Blin, Catherine Deguines, Philippe Derambure, Patrice Dosquet, Jean Pierre Duffet, Sylvia Goni, Philippe Gustovic, Marie Lang, Marie-Laure Laroche, Antoine Pariente, Jean-Jacques Pere, Odile Regnier, Philippe Truffinet
Publikováno v:
Therapies. 65:277-283
Resume Le developpement clinique de medicaments disease-modifiers dans la maladie d’Alzheimer se heurte a des difficultes methodologiques dont temoignent plusieurs echecs recents de medicaments en phase III. Compte-tenu des enjeux financiers inhere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0143dd98c706bb29a21547b4c6c0f99b
https://doi.org/10.2515/therapie/2010039
https://doi.org/10.2515/therapie/2010039
Autor:
Régis, Bordet, Jean-François, Dartigues, Bruno, Dubois, Jean-Marie, Goehrs, Laura, Vernoux, Franck, Semah, Florence, Pasquier, Claude, Bidaut-Mazel, Philippe, Truffinet
Publikováno v:
Therapie. 65(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::56f33a778f3788c95c7c9dd8ded90967
https://pubmed.ncbi.nlm.nih.gov/27393108
https://pubmed.ncbi.nlm.nih.gov/27393108
Autor:
Régis Bordet, Jean-François Dartigues, Bruno Dubois, Jean-Marie Goehrs, Laura Vernoux, Franck Semah, Florence Pasquier, Claude Bidaut-Mazel, Zeina Antoun, Olivier Arnaud, Olivier Blin, Antoine Coquerel, Catherine Deguines, Philippe Derambure, Patrice Dosquet, Jean-Pierre Duffet, Sylvia Goni, Philippe Gustovic, Marie Lang, Marie-Laure Laroche, Antoine Pariente, Jean-Jacques Pere, Odile Regnier, Philippe Truffinet
Publikováno v:
Therapie. 65(4)
As the failure of several recent Phase III drug development programmes bears witness, the clinical development of “disease-modifying” drugs in Alzheimer’s disease has been confronted with challenging methodological difficulties. Taking into acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d59afa840e517b81a8ffd59acd350f1
https://pubmed.ncbi.nlm.nih.gov/20854749
https://pubmed.ncbi.nlm.nih.gov/20854749